These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21276289)

  • 1. Treatment of multidrug-resistant tuberculosis: definition of the outcome 'failure'.
    Chiang CY; Van Deun A; Trébucq A; Heldal E; Caminero JA; Aït-Khaled N
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):4-5. PubMed ID: 21276289
    [No Abstract]   [Full Text] [Related]  

  • 2. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 3. Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment.
    Kurbatova EV; Gammino VM; Bayona J; Becerra M; Danilovitz M; Falzon D; Gelmanova I; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riekstina V; Taylor A; Viiklepp P; Zignol M; Cegielski JP
    Int J Tuberc Lung Dis; 2011 Nov; 15(11):1553-5, i. PubMed ID: 22008772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones.
    Chiang CY
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1319. PubMed ID: 19861001
    [No Abstract]   [Full Text] [Related]  

  • 5. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
    Jonsson G; Furin J
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):4-5. PubMed ID: 22236840
    [No Abstract]   [Full Text] [Related]  

  • 6. The "source" of drug-resistant TB outbreaks.
    van Helden PD; Victor T; Warren RM
    Science; 2006 Oct; 314(5798):419-20. PubMed ID: 17053131
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDR-TB and XDR-TB: drug resistance and treatment outcomes.
    Migliori GB; Sotgiu G; D'Arcy Richardson M; Centis R; Facchini A; Guenther G; Spanevello A; Lange C;
    Eur Respir J; 2009 Sep; 34(3):778-9. PubMed ID: 19720816
    [No Abstract]   [Full Text] [Related]  

  • 9. Infectious disease. Approval of novel TB drug celebrated--with restraint.
    Cohen J
    Science; 2013 Jan; 339(6116):130. PubMed ID: 23307714
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories.
    Van Deun A; Wright A; Zignol M; Weyer K; Rieder HL
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):116-24. PubMed ID: 21276307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical experience of using clofazimine to treat multidrug-resistant tuberculosis [Correspondence].
    Yoo JW; Lyu J; Lee SD; Kim WS; Kim DS; Shim TS
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1243-4. PubMed ID: 23928173
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing drug resistant tuberculosis.
    Grant A; Gothard P; Thwaites G
    BMJ; 2008 Aug; 337():a1110. PubMed ID: 18755763
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of drug resistance in Mycobacterium tuberculosis.
    Zhang Y; Yew WW
    Int J Tuberc Lung Dis; 2009 Nov; 13(11):1320-30. PubMed ID: 19861002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linezolid in the treatment of drug-resistant tuberculosis: the way forward?
    Yew WW; Lange C
    Int J Tuberc Lung Dis; 2014 Jun; 18(6):631-2. PubMed ID: 24903928
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.
    Qi W; Harries AD; Hinderaker SG
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):137-9. PubMed ID: 21276311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid identification of multidrug-resistant tuberculosis isolates in treatment failure or relapse patients in Bangui, Central African Republic.
    Minime-Lingoupou F; Pierre-Audigier C; Kassa-Kélémbho E; Barilone N; Zandanga G; Rauzier J; Cadet-Daniel V; Le Faou A; Gicquel B
    Int J Tuberc Lung Dis; 2010 Jun; 14(6):782-5. PubMed ID: 20487620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of extensively drug-resistant tuberculosis.
    Khurana AK; Mohapatra PR
    Eur Respir J; 2009 Sep; 34(3):780; author reply 780-1. PubMed ID: 19720817
    [No Abstract]   [Full Text] [Related]  

  • 19. Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Furin J; Diacon AH; Andries K
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):4-5. PubMed ID: 28157457
    [No Abstract]   [Full Text] [Related]  

  • 20. Antimicrobial resistance in tuberculosis: an international perspective.
    van Helden PD; Donald PR; Victor TC; Schaaf HS; Hoal EG; Walzl G; Warren RM
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):759-66. PubMed ID: 17140353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.